Hybrid physiologically‐based pharmacokinetic model for remdesivir: Application to SARS‐CoV‐2
Abstract A novel coronavirus, severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) or coronavirus disease 2019 (COVID‐19), has caused a pandemic that continues to cause catastrophic health and economic carnage and has escalated the identification and development of antiviral agents. Remdesiv...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Wiley,
2021-05-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|